Journal of Molecular and Clinical Medicine
Published by IMR Press.
Back to top
The publication of an article in a peer-reviewed journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of work of the author and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important that the authors accept the standards of expected ethical behavior.
Ethics topics to consider when publishing:Originality and plagiarism
The authors should ensure that they have written entirely their original study, and if the authors have used the work and/or words of others, that this has been appropriately cited or quoted. We use Crossref Similarity Check (powered by iThenticate) to screen submitted content for originality.
Authorship credit should be based on the following points: (1) substantial contribution to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Each author should meet these four conditions.
All clinical trials must have been registered in a public repository at the beginning of the research process (prior to patient enrollment). Trial registration numbers should be included in the methods section. The registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization. For a list of registries that meet these requirements, please visit the WHO International Clinical Trials Registry Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information among clinicians, researchers, and patients, enhances public confidence in research, and is in accordance with the ICMJE guidelines.
Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. For studies involving people, medical records, and human tissues, documented review and approval from a formally constituted review board is required. For animal research, please confirm that ethical and legal approval was obtained prior to the commencement of the study. The name of the body giving the approval must be provided upon manuscript submission. Relevant institutional and national guidelines and regulations that all the experiments followed should also be noted in the method part of the manuscript.
In case where any tissues, images, or videos relating to individual participants are included in the manuscript, the author should obtain the written consent to the inclusion of material pertaining to the patients. The editor of Journal of Molecular and Clinical Medicine (JMCM) reserves the right to ask the author to provide the signed consents.
Please confirm that all mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.
Journal of Molecular and Clinical Medicine (JMCM) requires that all authors, peer reviewers and editors disclose all potential conflicts of interests. All authors must complete the International Committee of Medical Journal Editors (ICMJE) form for Disclosure of Potential Conflicts of Interest and include the disclosure statement under the subheading “conflict of interest.” If authors have no interests to declare, please state that: “The authors declare no conflict of interest. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.
Duplicate or redundant publication
Only the original manuscripts that are not also published or going to be published elsewhere are accepted for publication in JMCM. Duplicate publications, or redundant publications will be rejected. If duplication is detected after publication, the Editor-in-Chief reserves the right to publish a notice to state this fact without the authors' approval. Competing manuscripts on the same study, for example by collaborators who have split into rival teams after the data were gathered, are acceptable only under special circumstances: please contact the Editor-in-Chief for advice.
The funding information should be included under the subheading “acknowledgement” of each published article.
After acceptance, the corresponding author will receive the galley proofs within 4 weeks and they are requested to carefully review them for data and typesetting errors. Corrections to proofs must be returned as soon as possible to avoid any delay in publication.
Availability of materials and data
It is expected that authors should be able to provide any materials and/or protocols used in published experiments to other qualified researchers for their own use. Materials include for example (but are not limited to): Cells, DNA, RNA, proteins, antibodies, reagents, organisms and mouse strains. These should be made available in a timely manner and it is acceptable to request reasonable payment to cover the cost of maintenance and shipment. For materials such as mutant strains and cell lines, authors should use established public repositories and provide relevant accession numbers wherever possible.
Articles in Press (articles that have been accepted for publication but which have not been formally published and will not yet have the complete issue/volume/page information) that include errors, or are discovered to be accidental duplicates of other published article(s), or are determined to violate our journal publishing ethics guidelines in the view of the editors (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like, will be “Withdrawn” from JMCM.
Changes to published articles that affect the interpretation and conclusion of the article, but do not fully invalidate the article are allowable at the Editor’s discretion via publication of an Erratum that is indexed and linked to the original article.
Published articles that contain infringements of professional ethical codes, such as multiple submissions, bogus claims of authorship, plagiarism, fraudulent use of data or the like are retracted.
A retraction note entitled “Retraction: [article title]” signed by the authors and/or the Editor-in-Chief is published in the paginated part of a subsequent issue of the journal and listed in the contents list. In the electronic version, a link is made to the original article. The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself. The original article is retained unchanged with a watermark on the PDF indicating on each page that it is “retracted.” The HTML version of the document is removed.
In cases where the authors of the original article wish to retract the flawed original and replace it with a corrected version, the procedures for retraction will be followed with the difference that the database retraction notice will publish a link to the corrected re-published article and a history of the document.
Readers of JMCM are encouraged to submit feedback to the Editor-in-Chief that support or criticize the previous publications. The Editor-in-Chief may consult with the original authorship of a publication or seek the advice of peer-reviewers to determine an appropriate response in cases where significant errors are found.
If the feedback is of significant interest, it may be considered for publication as a “Letter to the Editor “at the discretion of the Editor-in-Chief. In these cases, the original authorship of a publication may be given the chance to respond to the feedback in a published “Reply to” or “Response to” article.